It’s Better to Hope for Prosperity than Become Adversary: Larimar Therapeutics Inc (LRMR) Stock
Leerink Partners raised the price target for the Larimar Therapeutics Inc (NASDAQ:LRMR) stock to “an Outperform”. The rating was released on April 03, 2024, according to finviz. The research report from Guggenheim has initiated the stock to Buy, with a price target set at $12. The latest trade, Performances and Moving Averages give us the […]